Why Did Surgery Partners Inc (SGRY) Stock See -36.10% Plunge in the Last 90 Days?
UBS has recently initiated Surgery Partners Inc (SGRY) stock to Buy rating, as announced on October 14, 2024, according to Finviz. Earlier, on October 11, 2024, KeyBanc Capital Markets had initiated the stock to Sector Weight. Macquarie also initiated Outperform rating with a price target of $31. Additionally, Barclays initiated Equal Weight rating on March […]
What Factors Have Led to Surgery Partners Inc (SGRY) Stock Trading -38.99% Below Its 52-Week High?
UBS has recently initiated Surgery Partners Inc (SGRY) stock to Buy rating, as announced on October 14, 2024, according to Finviz. Earlier, on October 11, 2024, KeyBanc Capital Markets had initiated the stock to Sector Weight. Macquarie also initiated Outperform rating with a price target of $31. Additionally, Barclays initiated Equal Weight rating on March […]
Surgery Partners Inc (SGRY) Posted -2.03% Profit Margin Last Year—Can It Hold Up?
UBS has recently initiated Surgery Partners Inc (SGRY) stock to Buy rating, as announced on October 14, 2024, according to Finviz. Earlier, on October 11, 2024, KeyBanc Capital Markets had initiated the stock to Sector Weight. Macquarie also initiated Outperform rating with a price target of $31. Additionally, Barclays initiated Equal Weight rating on March […]
Surgery Partners Inc (SGRY) Stock Settles at $23.41: What’s Contributing to This Price Point?
UBS has recently initiated Surgery Partners Inc (SGRY) stock to Buy rating, as announced on October 14, 2024, according to Finviz. Earlier, on October 11, 2024, KeyBanc Capital Markets had initiated the stock to Sector Weight. Macquarie also initiated Outperform rating with a price target of $31. Additionally, Barclays initiated Equal Weight rating on March […]
Surgery Partners Inc (SGRY) Stock: More Robust Than the Numbers Suggest?
UBS has recently initiated Surgery Partners Inc (SGRY) stock to Buy rating, as announced on October 14, 2024, according to Finviz. Earlier, on October 11, 2024, KeyBanc Capital Markets had initiated the stock to Sector Weight. Macquarie also initiated Outperform rating with a price target of $31. Additionally, Barclays initiated Equal Weight rating on March […]
The Surgery Partners Inc Rollercoaster: What’s Behind the Latest SGRY Stock Fluctuation?
UBS has recently initiated Surgery Partners Inc (SGRY) stock to Buy rating, as announced on October 14, 2024, according to Finviz. Earlier, on October 11, 2024, KeyBanc Capital Markets had initiated the stock to Sector Weight. Macquarie also initiated Outperform rating with a price target of $31. Additionally, Barclays initiated Equal Weight rating on March […]
What’s Behind the -13.76% Drop in Surgery Partners Inc (SGRY) Stock? Find Out Now!
UBS has recently initiated Surgery Partners Inc (SGRY) stock to Buy rating, as announced on October 14, 2024, according to Finviz. Earlier, on October 11, 2024, KeyBanc Capital Markets had initiated the stock to Sector Weight. Macquarie also initiated Outperform rating with a price target of $31. Additionally, Barclays initiated Equal Weight rating on March […]
What’s Fueling Surgery Partners Inc (SGRY) Stock’s 9.06% Gain Above Its 200-Day SMA?
UBS has recently initiated Surgery Partners Inc (SGRY) stock to Buy rating, as announced on October 14, 2024, according to Finviz. Earlier, on October 11, 2024, KeyBanc Capital Markets had initiated the stock to Sector Weight. Macquarie also initiated Outperform rating with a price target of $31. Additionally, Barclays initiated Equal Weight rating on March […]
Surgery Partners Inc (SGRY) Stock: Unveiling Its Hidden Strengths
UBS has recently initiated Surgery Partners Inc (SGRY) stock to Buy rating, as announced on October 14, 2024, according to Finviz. Earlier, on October 11, 2024, KeyBanc Capital Markets had initiated the stock to Sector Weight. Macquarie also initiated Outperform rating with a price target of $31. Additionally, Barclays initiated Equal Weight rating on March […]
Surgery Partners Inc (SGRY) Stock Price Reaches $31.59: What Factors Are Influencing This Level?
UBS has recently initiated Surgery Partners Inc (SGRY) stock to Buy rating, as announced on October 14, 2024, according to Finviz. Earlier, on October 11, 2024, KeyBanc Capital Markets had initiated the stock to Sector Weight. Macquarie also initiated Outperform rating with a price target of $31. Additionally, Barclays initiated Equal Weight rating on March […]
